Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuwen Lin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
BMC Cancer|January 16, 2026
High endothelial venules abundance in tertiary lymphoid structures: a prognostic biomarker in non-small cell lung cancer with neoadjuvant immunochemotherapyYinguang Zhang, Mei Xie, Jie Gao, et al.
International Immunopharmacology|August 1, 2024
Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosisXin Zhang, Jie Yao, Mei Xie, et al.
Frontiers in Immunology|July 19, 2024
Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacyXinyu Bao, Xuwen Lin, Mei Xie, et al.
Cancer Management and Research|June 12, 2025
Advances in Multimodal Imaging Techniques for Evaluating and Predicting the Efficacy of Immunotherapy for NSCLCJingyi Liu, Mei Xie, Jing Shen, et al.
Clinical and Translational Medicine|March 7, 2024
Immune-related adverse events in non-small cell lung cancer: Occurrence, mechanisms and therapeutic strategiesXuwen Lin, Mei Xie, Jie Yao, et al.
Talanta|November 24, 2024
Latex microspheres lateral flow immunoassay with smartphone-based device for rapid detection of CryptococcusXuelei Zang, Yangyu Zhou, Shuming Li, et al.
The Journal of Clinical Investigation|February 2, 2026
Proanthocyanidins enhance antitumor immunity by promoting ubiquitin-proteasomal PD-L1 degradation via stabilization of LKB1 and SYVN1Mengting Xu, Xuwen Lin, Hanchi Xu, et al.
Journal of Thoracic Disease|November 13, 2025
Continuing immune checkpoint inhibitors after pseudoprogression improves survival in lung cancer patients: a systematic review and meta-analysisAiben Huang, Mei Xie, Chongchong Wu, et al.
Cell Reports. Medicine|July 13, 2026
Repurposed ethoxzolamide reprograms antitumor immunity through β-TrCP-dependent PD-L1 ubiquitinationXuwen Lin, Qun Wang, Mengting Xu, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
BMC Cancer|January 16, 2026
High endothelial venules abundance in tertiary lymphoid structures: a prognostic biomarker in non-small cell lung cancer with neoadjuvant immunochemotherapyYinguang Zhang, Mei Xie, Jie Gao, et al.
International Immunopharmacology|August 1, 2024
Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosisXin Zhang, Jie Yao, Mei Xie, et al.
Frontiers in Immunology|July 19, 2024
Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacyXinyu Bao, Xuwen Lin, Mei Xie, et al.
Cancer Management and Research|June 12, 2025
Advances in Multimodal Imaging Techniques for Evaluating and Predicting the Efficacy of Immunotherapy for NSCLCJingyi Liu, Mei Xie, Jing Shen, et al.
Clinical and Translational Medicine|March 7, 2024
Immune-related adverse events in non-small cell lung cancer: Occurrence, mechanisms and therapeutic strategiesXuwen Lin, Mei Xie, Jie Yao, et al.
Talanta|November 24, 2024
Latex microspheres lateral flow immunoassay with smartphone-based device for rapid detection of CryptococcusXuelei Zang, Yangyu Zhou, Shuming Li, et al.
The Journal of Clinical Investigation|February 2, 2026
Proanthocyanidins enhance antitumor immunity by promoting ubiquitin-proteasomal PD-L1 degradation via stabilization of LKB1 and SYVN1Mengting Xu, Xuwen Lin, Hanchi Xu, et al.
Journal of Thoracic Disease|November 13, 2025
Continuing immune checkpoint inhibitors after pseudoprogression improves survival in lung cancer patients: a systematic review and meta-analysisAiben Huang, Mei Xie, Chongchong Wu, et al.
Cell Reports. Medicine|July 13, 2026
Repurposed ethoxzolamide reprograms antitumor immunity through β-TrCP-dependent PD-L1 ubiquitinationXuwen Lin, Qun Wang, Mengting Xu, et al.
Pageof 2